Rezolute Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Size Or Amount Disclosed
Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced that it is